Amicus Therapeutics Inc. (FOLD)
8.20
-0.23 (-2.73%)
At close: Mar 31, 2025, 3:37 PM
Amicus Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 |
| Revenue | 528.29M | 399.36M | 329.23M | 305.51M | 260.89M | 182.24M | 91.25M | 36.93M | 4.96M | n/a | 1.22M | 363K | 18.41M | 21.43M | 922K | 64.36M | 14.97M | 1.78M | n/a | n/a | n/a | n/a |
| Cost of Revenue | 52.94M | 37.33M | 38.6M | 34.47M | 31.04M | 21.96M | 14.4M | 6.24M | 833K | 1.83M | n/a | 13.49M | 20.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 475.35M | 362.03M | 290.63M | 271.05M | 229.84M | 160.27M | 76.84M | 30.69M | 4.13M | -1.83M | 1.22M | -13.13M | -1.97M | 21.43M | 922K | 64.36M | 14.97M | 1.78M | n/a | n/a | n/a | n/a |
| Operating Income | 24.88M | -73.49M | -204.43M | -199.92M | -243.85M | -300.74M | -328.78M | -441.99M | -181.89M | -130.44M | -68.7M | -64.18M | -52.93M | -50.89M | -55.84M | -7.35M | -43.96M | -45.8M | -46.86M | -20.83M | -8.81M | -6.6M |
| Interest Income | 5.41M | 7.08M | 3.02M | 509K | 3.23M | 10.25M | 10.46M | 4.1M | 1.6M | 929K | 223K | 174K | 316K | 160K | 156K | 997K | 4.82M | n/a | 1.99M | 609.52K | n/a | 5K |
| Pretax Income | -28.76M | -150.1M | -242.04M | -241.55M | -274.25M | -355.91M | -349.09M | -449.12M | -203.78M | -132.12M | -70.04M | -63.15M | -52.03M | -48.04M | -56.08M | -6.57M | -39.35M | -41.17M | -46.34M | -20.58M | n/a | -6.77M |
| Net Income | -56.11M | -151.58M | -236.57M | -250.46M | -276.85M | -356.39M | -349M | -284M | -200.04M | -132.12M | -68.93M | -59.63M | -48.78M | -44.41M | -54.94M | -6.57M | -39.35M | -41.17M | -46.34M | -19.97M | -8.81M | -6.77M |
| Selling & General & Admin | 323.38M | 275.27M | 213.04M | 192.71M | 156.41M | 169.86M | 127.2M | 88.67M | 71.15M | 47.27M | 20.72M | 18.89M | 19.36M | 19.88M | 15.66M | 19.97M | 19.67M | 15.28M | 12.28M | 6.88M | n/a | n/a |
| Research & Development | 109.36M | 152.38M | 276.68M | 272.05M | 308.44M | 286.38M | 270.9M | 149.31M | 104.79M | 76.94M | 47.62M | 41.94M | 50.27M | 50.86M | 39.04M | 48.08M | 37.76M | 31.07M | 33.63M | 13.65M | n/a | 4.43M |
| Other Expenses | 17.73M | n/a | 5.34M | 6.21M | 8.85M | 4.78M | -5.63M | 6.01M | -4.79M | -80K | -77K | 1.72M | 21K | 1.58M | 2.06M | 2.13M | 1.49M | 1.24M | n/a | n/a | -8.81M | n/a |
| Operating Expenses | 450.48M | 427.65M | 495.06M | 470.97M | 473.7M | 461.01M | 402.32M | 241.57M | 179.19M | 126.05M | 69.89M | 62.56M | 71.34M | 72.32M | 56.76M | 70.19M | 58.92M | 47.59M | 46.86M | 20.83M | -8.81M | 6.6M |
| Interest Expense | 49.6M | 50.15M | 37.12M | 32.47M | 22.43M | 18.87M | 22.4M | 17.24M | 5.4M | 1.58M | 1.48M | 46K | 89K | 148K | 260K | 278K | 218K | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 503.42M | 472.85M | 533.66M | 505.43M | 504.74M | 482.98M | 416.72M | 247.81M | 180.02M | 126.05M | 69.89M | 62.56M | 71.34M | 72.32M | 56.76M | 70.19M | 58.92M | 47.59M | 46.86M | 20.83M | -8.81M | 6.6M |
| Income Tax | 27.35M | 1.48M | -5.47M | 8.91M | 2.6M | 478K | -94K | -165.12M | -3.74M | 1.5M | -1.11M | -3.51M | -3.25M | -3.63M | -1.14M | 278K | n/a | 351K | -514.36K | -611.8K | 8.81M | n/a |
| Shares Outstanding (Basic) | 304.38M | 295.16M | 289.06M | 271.42M | 258.87M | 240.42M | 185.79M | 153.36M | 134.4M | 109.92M | 74.44M | 51.29M | 45.57M | 34.57M | 27.73M | 22.62M | 22.49M | 13.24M | 735.97K | 410.22K | 307.54K | 307.54K |
| Shares Outstanding (Diluted) | 304.38M | 295.16M | 289.06M | 271.42M | 258.87M | 240.42M | 185.79M | 153.36M | 134.4M | 109.92M | 74.44M | 51.29M | 45.57M | 34.57M | 27.73M | 22.62M | 22.49M | 13.24M | 735.97K | 410.22K | 307.54K | 307.54K |
| EPS (Basic) | -0.18 | -0.51 | -0.82 | -0.92 | -1.07 | -1.48 | -1.88 | -1.85 | -1.49 | -1.2 | -0.93 | -1.16 | -1.07 | -1.28 | -1.98 | -0.29 | -1.75 | -3.11 | -62.97 | -48.69 | -28.64 | -22.01 |
| EPS (Diluted) | -0.18 | -0.51 | -0.82 | -0.92 | -1.07 | -1.48 | -1.88 | -1.85 | -1.49 | -1.2 | -0.93 | -1.16 | -1.07 | -1.28 | -1.98 | -0.29 | -1.75 | -3.11 | -62.97 | -48.69 | -28.64 | -22.01 |
| EBITDA | 29.39M | -92.08M | -199.58M | -202.87M | -242.98M | -332.26M | -322.47M | -428.29M | -195.14M | -128.71M | -67.01M | -61.38M | -50.24M | -46.54M | -53.76M | -4.16M | -37.64M | -44.57M | -44.7M | -20.2M | -8.81M | -6.47M |
| Depreciation & Amortization | 8.55M | 7.87M | 5.34M | 6.21M | 8.85M | 4.78M | 4.22M | 3.59M | 3.24M | 1.83M | 1.55M | 1.72M | 1.71M | 1.58M | 2.06M | 2.13M | 1.49M | 1.24M | 952.45K | 667.38K | n/a | 132K |